课题基金 / 基金详情

NIAID PRECLINICAL DEVELOPMENT SUPPORT - IMMUNOAFFINITY PURIFICATION OF HIV-1 ENV PROTEINS

NIAID PRECLINICAL DEVELOPMENT SUPPORT - IMMUNOAFFINITY PURIFICATION OF HIV-1 ENV PROTEINS
NIAID 临床前开发支持 - HIV-1 ENV 蛋白的免疫亲和纯化
批准号：
10610267
负责人：
THOMAS VANCOTT
金额：
$34.63万
依托单位：
ADVANCED BIOSCIENCE LABORATORIES, INC.
依托单位国家：
美国
项目类别：
财政年份：
2016
资助国家：
美国
项目状态：
已结题
起止时间：
2016-09-15 至 2021-08-28
来源：
https://reporter.nih.gov/project-details/10610267
关键词：
ContractsDevelopmentDocumentationHIV-1Investigational DrugsInvestigator-Initiated ResearchNational Institute of Allergy and Infectious DiseasePhasePreclinical TestingProductionenv Gene Productsflexibilitypreclinical developmentresearch clinical testingresearch study

项目摘要

项目成果

THOMAS VANCOTT的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This contract will provide NIAID with a broad and flexible range of nontraditional, proactive and developmentally-oriented capabilities to provide preclinical development support for promising products when such products emerge from investigator-initiated research studies. These capabilities will allow NIAID to more rapidly and efficiently close development and production gaps. Activities include but are not limited to small-scale production, preclinical testing and documentation leading to Investigational New Drug (IND) submission for Phase I, II, and III clinical testing. In particular this project will support the immunoaffinity purification of HIV-1 envelope proteins.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Essential Core Activities: NIAID Preclinical Development Support
NIAID Preclinical Development Support: Adjuvants for HIV-1 Vaccines
ESSENTIAL CORE ACTIVITIES, NIAID PRECLIN DEVELOPMENT SUPPORT
Essential Core Activities: NIAID Preclinical Development Support
国内基金
海外基金
水稻边界发育缺陷突变体abnormal boundary development(abd)的基因克隆与功能分析
Development of a Linear Stochastic Model for Wind Field Reconstruction from Limited Measurement Data
  • 批准号：
    --
  • 项目类别：
    --
  • 资助金额：
    40万元
  • 批准年份：
    2020
  • 负责人：
    Vikrant Gupta
  • 依托单位：
    南方科技大学